XPro™ Could Be the Holy Grail in Alzheimer’s Treatment — And INmune Bio (INMB) Owns It
INmune Bio Inc. (NASDAQ:INMB)is a clinical-stage biotechnology company pioneering a new frontier in immunotherapy by targeting the innate…
Browsing Tag